cimadronate has been researched along with Body Weight in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Kanoh, H; Kawashima, H; Motoie, H; Nakamura, T; Nishikawa, H; O'uchi, N | 1 |
| Endo, N; Mashiba, T; Nishida, S; Takahashi, HE; Takano, Y; Tanizawa, T | 1 |
| Fujikura, T; Kanoh, H; Motoie, H; Okazaki, A; Shikama, H | 1 |
| Kaji, Y; Kawanishi, J; Komatsubara, S; Li, J; Mashiba, T; Mori, S; Norimatsu, H; Taki, M | 1 |
| Kikuchi, T; Kudo, H; Mitamura, T; Sakamoto, S; Sassa, S; Shinoda, H; Suzuki, S; Yoshimura, S; Zhou, Y | 1 |
| Akiyama, T; Kaji, Y; Kawanishi, J; Li, J; Mori, S; Norimatsu, H | 1 |
6 other study(ies) available for cimadronate and Body Weight
| Article | Year |
|---|---|
Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
Topics: Administration, Oral; Alkaline Phosphatase; Analysis of Variance; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcium; Dihydroxycholecalciferols; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Female; Femur; Femur Neck; Humans; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Ovariectomy; Random Allocation; Regression Analysis | 1995 |
Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
Topics: Animals; Body Weight; Bone Density; Bone Development; Diphosphonates; Drug Administration Schedule; Drug Therapy, Combination; Female; Femur; Humans; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Teriparatide; Tibia | 1996 |
Increase of bone mass and mechanical strength in rats after treatment with a novel bisphosphonate, YM175, for two years.
Topics: Animals; Body Weight; Bone and Bones; Diphosphonates; Female; Humerus; Male; Mortality; Rats; Rats, Inbred F344 | 1997 |
Preadministration of incadronate disodium can prevent bone loss in rat proximal tibial metaphysis when induced by hindlimb immobilization by bandage.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Diphosphonates; Disease Models, Animal; Female; Hindlimb; Image Processing, Computer-Assisted; Immobilization; Rats; Rats, Sprague-Dawley; Tibia | 1998 |
Prevention of osteopenia induced with a gonadotropin-releasing hormone agonist in rats.
Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Estradiol; Estrogens, Conjugated (USP); Female; Femur; Fertility Agents, Female; Follicle Stimulating Hormone; Hydroxycholecalciferols; Leuprolide; Luteinizing Hormone; Organ Size; Ovariectomy; Radiography; Rats; Rats, Sprague-Dawley | 1999 |
Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats.
Topics: Animals; Apoptosis; Body Weight; Bony Callus; Cell Count; Diphosphonates; Female; Femoral Fractures; Histocytochemistry; In Situ Hybridization; Osteoclasts; Radiography; Rats; Rats, Sprague-Dawley; Wound Healing | 2000 |